Skip to main content

Stevanato Group S.p.A.

STVN
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001849853

In the last 90 days, Stevanato Group S.p.A. insiders filed 0 open-market purchases and 4 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $808.8M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Stevanato Group S.p.A. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of STVN: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders8073−7
Shares36.3M32.5M−3.74M (−10.3%)
Value$814.2M$654.3M−$159.9M (−19.6%)

New holders (15)

Institutions that held Stevanato Group S.p.A. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to STVN in Q1 2022
InstitutionSharesValue% of portfolio
Royce & Associates LP245,159$4.93M0.04%
Roubaix Capital, LLC208,520$4.20M2.89%
Silvercrest Asset Management Group LLC177,280$3.57M0.02%
Schwartz Investment Counsel Inc73,881$1.49M0.06%
Tekla Capital Management LLC71,190$1.43M0.05%
Alpha Paradigm Partners, LLC28,850$580.0K0.23%
Mirabella Financial Services LLP14,967$301.0K0.03%
Cubist Systematic Strategies, LLC11,827$238.0K0.00%
Parametric Portfolio Associates LLC11,078$223.0K0.00%
Trexquant Investment LP10,644$214.0K0.01%
Royal Bank of Canada6,873$138.0K0.00%
First Horizon Advisors, Inc.3,252$65.0K0.00%
Fairfield Financial Advisors, LTD200$4.02K0.00%
Northwestern Mutual Wealth Management Co166$3.00K0.00%
Brewin Dolphin Wealth Management Ltd173$3.00K0.00%

Sold out (22)

Institutions that held Stevanato Group S.p.A. at the end of Q4 2021 and filed for Q1 2022 without it.